ESPR vs. NGD

Last updated Jun 13, 2026

ESPR (Esperion Therapeutics, Inc.) and NGD (New Gold Inc.) are both stocks. ESPR operates in Biotechnology (Healthcare), while NGD operates in Gold (Basic Materials). At a 0.06 correlation, their price movements are largely independent.

Performance

ESPR vs. NGD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Esperion Therapeutics, Inc. (ESPR) and New Gold Inc. (NGD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ESPR

• 1D: 0.00%
• 1M: 0.96%
• YTD: -14.86%
• 6M: -18.18%
• 1Y: 162.50%
• 3Y*: 35.36%
• 5Y*: -34.62%
• 10Y*: -14.95%

NGD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ESPR vs. NGD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ESPR Esperion Therapeutics, Inc.	-14.86%	68.18%	-26.42%	-52.01%	24.60%	-80.77%	-56.40%	29.63%	-30.13%	425.88%
NGD New Gold Inc.	4.25%	251.21%	69.86%	48.98%	-34.67%	-31.51%	148.86%	16.28%	-77.00%	-6.00%

Correlation

The correlation between ESPR and NGD is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (10Y) Calculated over the trailing 10-year period	0.07
Correlation (All Time) Calculated using the full available price history since Jun 26, 2013	0.06

Fundamentals

EPS ESPR : -$0.03 NGD : $1.61
PS Ratio ESPR : 1.75 NGD : 3.30
Total Revenue (TTM) ESPR : $418.24M NGD : $1.46B
Gross Profit (TTM) ESPR : $226.32M NGD : $758.26M
EBITDA (TTM) ESPR : $77.18M NGD : $1.19B

Return for Risk

ESPR vs. NGD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ESPR

ESPR Risk / Return Rank: 86
ESPR Sharpe Ratio Rank: 87
ESPR Sortino Ratio Rank: 88
ESPR Omega Ratio Rank: 87
ESPR Calmar Ratio Rank: 84
ESPR Martin Ratio Rank: 84

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ESPR vs. NGD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and New Gold Inc. (NGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ESPR	NGD	Difference
Sharpe ratio: Return per unit of total volatility	1.76	—	—
Sortino ratio: Return per unit of downside risk	2.86	—	—
Omega ratio: Gain probability vs. loss probability	1.36	—	—
Calmar ratio: Return relative to maximum drawdown	3.07	—	—
Martin ratio: Return relative to average drawdown	7.68	—	—

Drawdowns

Drawdown Indicators

	ESPR	NGD	Difference
Max Drawdown Largest peak-to-trough decline	-99.37%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-53.19%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-80.94%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-97.16%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.10%	—	—
Current Drawdown Current decline from peak	-97.27%	—	—
Average Drawdown Average peak-to-trough decline	-69.99%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	21.30%	—	—

Volatility

Volatility by Period

	ESPR	NGD	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.06%	—	—
Volatility (6M) Calculated over the trailing 6-month period	61.44%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	92.66%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	91.79%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	84.61%	—	—

Dividends

ESPR vs. NGD - Dividend Comparison

Neither ESPR nor NGD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ESPR and NGD in my portfolio?

ESPR and NGD have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.